Status:
UNKNOWN
A Registration Study for Dyslipidemia
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Atherosclerotic Vascular Diseases
Eligibility:
All Genders
20-90 years
Brief Summary
Cardiovascular disease (CVD), including coronary heart disease (CHD) and stroke, is a leading cause of morbidity and mortality. Dyslipidemia has long been recognized to be the most important risk fact...
Detailed Description
This is a registry study to define the status of lipid lowering therapy in Taiwan and the effect of LLT on CVD morbidity and mortality in a large population of patients receiving primary or secondary ...
Eligibility Criteria
Inclusion
- One with atherosclerotic vascular diseases
- One without ASVD but with at least 1 CV risk factor
- Apparent healthy persons
Exclusion
- One with hemodynamically significant valvular or congenital heart disease
- One with any non-cardiovascular diseases which may affect prognosis
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2017
Estimated Enrollment :
35000 Patients enrolled
Trial Details
Trial ID
NCT02223143
Start Date
January 1 2009
End Date
October 1 2017
Last Update
November 15 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NTUH
Taipei, Taiwan